Funding Opportunities

The WU-CDTR compiles and regularly updates a list of potential funding opportunities related to obesity, diabetes, and translational research.

In addition, the Washington University Office of the Vice Chancellor of Research maintains a comprehensive database of both internal and external funding resources. 

Information on the WU-CDTR pilot and feasibility program can be found here.

Source/FAO	Title	Due Date	Sponsor Name
PAR-19-274	Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)	None Posted	National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
	Educational Program Grants	None Posted	Diabetes Research and Wellness Foundation (U.S.)
RFA-DK-19-504	RFA-DK-19-504–Limited Competition: Continuation of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Management Center (CPDPC-CDMC) (U01 Clinical Trial Optional) (Defunct)	None posted	National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-DK-20-015	RFA-DK-20-015 — Patient-oriented Research to Mitigate Health Disparities and Lessen the Burden of Chronic Diseases Within the Mission of NIDDK (R01 Clinical Trial Optional) (Defunct)	None posted	National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
	Systems and Best Practices Grants	02-Apr-2021	Tufts Health Plan Foundation
PAR-19 -379	Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32)	08-Apr-2021	National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-DK-20-025	RFA-DK-20-025 — Diabetes Research Centers (P30 Clinical Trial Optional)	20-Apr-2021	National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-AI-20-078	RFA-AI-20-078 — Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)	05-May-2021	National Institute of Allergy and Infectious Diseases/NIH/DHHS
RFA-OD-20-016	RFA-OD-20-016 — Emergency Awards: RADx-RAD Multimodal COVID-19 Surveillance Methods for High Risk Clustered Populations (R01 Clinical Trial Optional)	07-May-2021	National Institutes of Health/DHHS
RFA-DK-20-032	RFA-DK-20-032 — Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required)	22-May-2021	National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-DK-19-004	RFA-DK-19-004 — Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)	01-Jun-2021	National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
NOT-DK-21-013	Notice of NIDDK Participation in PAR-19-274, “Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)”	05- Jun- 2021	National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
RFA-CA-20-028	RFA-CA-20-028 — Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)	30-Jun-2021	National Cancer Institute/NIH/DHHS
RFA-OD-19-029	RFA-OD-19-029 — The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)	26-Oct-2021	Office of Research on Women’s Health/NIH/DHHS
RFA-OD-20-003	RFA-OD-20-003 — Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)	04-Oct-2021	National Institutes of Health/DHHS

Last Updated March 30th, 2021